文献
J-GLOBAL ID:202202239848531334
整理番号:22A1154894
PARPとHSP90の複合阻害:進行性固形腫瘍患者における前臨床および第1相評価【JST・京大機械翻訳】
Combined PARP and HSP90 inhibition: preclinical and Phase 1 evaluation in patients with advanced solid tumours
著者 (23件):
Konstantinopoulos Panagiotis A.
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Cheng Su-Chun
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Supko Jeffrey G.
(Massachusetts General Hospital, Boston, MA, USA)
,
Polak Madeline
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Wahner-Hendrickson Andrea E.
(Mayo Clinic, Rochester, MN, USA)
,
Ivy S. Percy
(National Cancer Institute, Bethesda, MD, USA)
,
Bowes Brittany
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Sawyer Hannah
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Basada Patrice
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Hayes Martin
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Curtis Jennifer
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Horowitz Neil
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Wright Alexi A.
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Campos Susana M.
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Ivanova Elena V.
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Paweletz Cloud P.
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Palakurthi Sangeetha
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Liu Joyce F.
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
D’Andrea Alan D.
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Gokhale Prafulla C.
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Chowdhury Dipanjan
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Matulonis Ursula A.
(Dana-Farber Cancer Institute, Boston, MA, USA)
,
Shapiro Geoffrey I.
(Dana-Farber Cancer Institute, Boston, MA, USA)
資料名:
British Journal of Cancer
(British Journal of Cancer)
巻:
126
号:
7
ページ:
1027-1036
発行年:
2022年
JST資料番号:
C0922B
ISSN:
0007-0920
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)